Status:
ACTIVE_NOT_RECRUITING
Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
CoV2 Positive Caregivers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Covid-SER is a prospective multi-center study for the evaluation of diagnostic performance of available serological tests
Eligibility Criteria
Inclusion
- Seropositive caregivers screened for anti-SARS CoV2 antibodies during their consultation at the occupational medicine of HCL.
- Age: ≥ 18 years old
- Persons having given their written consent and accepting a follow-up every 6 months for 24 months, followed by a final visit at 36 months.
- Persons affiliated to a social security scheme or beneficiary of such a scheme.
Exclusion
- Pregnant or lactating woman
Key Trial Info
Start Date :
April 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 10 2026
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT04341142
Start Date
April 10 2020
End Date
October 10 2026
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Lyon Sud,Sainte Eugénie bat 4M,5, Chemin du Grand Revoyet
Pierre-Bénite, France, 69495